A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2004
10/20/2004	EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004	EP1140941B1 Nitrogen containing heterobicycles as factor xa inhibitors
10/20/2004	EP1121142B1 Angiogenically effective unit dose of fgf-2 and use thereof
10/20/2004	EP0983071B1 Use of hypothalamic inhibitory factor in the treatment of ischemic cardiac malfunction
10/20/2004	EP0850062B1 Use of halofuginone for the preparation of a medicament for attenuating neovascularization and for treating human malignant tumours
10/20/2004	CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists
10/20/2004	CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004	CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/20/2004	CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them
10/20/2004	CN1538959A Fused-polycyclic compounds
10/20/2004	CN1538957A Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
10/20/2004	CN1538956A Spiro compounds
10/20/2004	CN1538955A Pyrrolidine derivatives as factor Xa inhibitors
10/20/2004	CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1538845A Phenyl derivatives as factor Xa inhibitors
10/20/2004	CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
10/20/2004	CN1538836A Substituted amine derivatives and method of use
10/20/2004	CN1537946A Method of extracting dietary fiber from sogbean drges and chewing tablet
10/20/2004	CN1537938A New earthoworm plasmin and its preparation method
10/20/2004	CN1537857A Compound, its preparation method and its application
10/20/2004	CN1537651A Health-care heat protecter with gold, silver and Chinese medicines and its manufacturing method
10/20/2004	CN1537632A Health-care food for preventing and treating hyperlipoidemia
10/20/2004	CN1537628A Purpleblow maple lozenge for health-care,and its prepn. method
10/20/2004	CN1537612A Capsule for treating myocarditis of coxsackie B virus type, and its prepn.method
10/20/2004	CN1537602A Traditional Chinese medicine pill for taking care of heart, brain and kidney
10/20/2004	CN1537567A Art for extracting red sage root water soluble ingredient and removing impurities
10/20/2004	CN1537566A Pure herb medicine prepn. contg. acer truncatum and others, and its prepn. method
10/20/2004	CN1537562A Compound flavone capsule and pellet prepn. method
10/20/2004	CN1537556A Traditional Chinese medicine pill-Naoxin-Kangtai-Pill for treating cerebrovasular and cardiovascular disease
10/20/2004	CN1537554A Traditional Chinese medicine composition for treating cardiovascular disease
10/20/2004	CN1537547A Applicaton of chinese angelica-root for preparing medicine for treating hypertension disease
10/20/2004	CN1537540A Medicine composition for treating cerebrovascular disease
10/20/2004	CN1537538A Method for preparing compound flavone spray
10/20/2004	CN1537531A Celecoxib compositions
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/20/2004	CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same
10/20/2004	CN1171899C Structure and usage of plasminogen activator (TPA) mutant
10/20/2004	CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
10/20/2004	CN1171883C Nonsteroidal antiinflammatories
10/20/2004	CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer
10/20/2004	CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004	CN1171861C Halogenated amidino amino acid dervatives useful as nitric oxide synthase inhibitors
10/20/2004	CN1171855C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril
10/20/2004	CN1171627C Oral pill for treatment of piles
10/20/2004	CN1171626C External treatment powder for piles
10/20/2004	CN1171621C Xuemaitong medcine for promoting blood circulation and its producing method
10/20/2004	CN1171610C Traditional Chinese medcine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method
10/19/2004	US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004	US6806312 Thermoplastic resin composition
10/19/2004	US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004	US6806274 Quinazoline derivatives
10/19/2004	US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
10/19/2004	US6806063 Protein conjugate for use in the treatment of blood disorder
10/19/2004	US6805878 Transdermal administration of ACE inhibitors
10/19/2004	US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas
10/19/2004	CA2296901C Piperidine derivates having anxiolytic effect
10/18/2004	CA2426115A1 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
10/14/2004	WO2004087938A1 Novel physiologically active substances pf1270a, b and c
10/14/2004	WO2004087734A2 Stq-peptides
10/14/2004	WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
10/14/2004	WO2004087680A1 Novel quinazoline derivatives and methods of treatment related to the use thereof
10/14/2004	WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004	WO2004087646A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
10/14/2004	WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors
10/14/2004	WO2004087182A1 Active ingredient combinations of plant oils containing $g(v)3-fatty acids and plant extracts containing isoprenoids and the use thereof
10/14/2004	WO2004087172A1 T-type calcium channel blockers
10/14/2004	WO2004087132A2 Combination drug therapy for treating hypertension
10/14/2004	WO2004087120A2 Use of quinazoline derivatives with src kinase inhibitory activity for the treatment of hypertension
10/14/2004	WO2004087063A2 Use of erythropoietin in stroke recovery
10/14/2004	WO2004086880A1 Sodium chloride-containing foods and drinks
10/14/2004	WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages)
10/14/2004	WO2004071392A8 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4)
10/14/2004	WO2004044229A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2)
10/14/2004	WO2004043367A3 Fused heterocyclic compounds and use thereof
10/14/2004	WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
10/14/2004	WO2004042076A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a)
10/14/2004	WO2004041245B1 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases
10/14/2004	WO2004032840A3 Compounds, compositions, and methods
10/14/2004	WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
10/14/2004	WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators
10/14/2004	WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
10/14/2004	WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004	WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
10/14/2004	US20040204673 Modular infusion device and method
10/14/2004	US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004	US20040204564 CRFR1 selective ligands
10/14/2004	US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction
10/14/2004	US20040204482 provides a defined blood concentration profile having no rapid initial rise in blood plasma concentration of the good soluble active substance when administered; (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide; nervous system, gastrointestinal, heart disorders, Alzheimer's
10/14/2004	US20040204474 Hypotensive agents; cardiovascular disorders
10/14/2004	US20040204464 Isoxazoline compounds having MIF antagonist activity
10/14/2004	US20040204456 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
10/14/2004	US20040204455 For therapy of hypertension, and congestive heart failure
10/14/2004	US20040204449 New isoquinoline compounds
10/14/2004	US20040204437 Substituted arylamine derivatives and methods of use
10/14/2004	US20040204431 For therapy cardiovascular disease
10/14/2004	US20040204428 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments
10/14/2004	US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
10/14/2004	US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
10/14/2004	US20040204417 For therapy of cancer

1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 1595